Jun 21, 2019
Achieve Life Sciences Announces Phase 2b ORCA-1 Trial Data Accepted for Oral Presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference
May 29, 2019
Fellowship Offers 700 Free Meetings in 32 Countries to Help You Stop Smoking or Vaping Nicotine
Apr 30, 2019
FDA permits sale of IQOS Tobacco Heating System through premarket tobacco product application pathway
Apr 03, 2019
Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019
Apr 02, 2019
NYSVA Finds It Tragic that Budget Taxes New Yorkers for Quitting Smoking
Apr 02, 2019
Achieve Life Sciences Announces Successful Completion of the Second and Final DSMC Review of Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation
Apr 01, 2019
Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance treatment strategies for helping youth addicted to nicotine as a result of the epidemic rise in teen use of e-cigarettes
Mar 14, 2019
Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update
Mar 08, 2019
Global Nicotine Patch Market 2019-2023: Technological Innovations in Transdermal Drug Delivery Process
Feb 22, 2019
Achieve Announces Final Data from Cytisinicline Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study to be Presented at Society for Research on Nicotine & Tobacco Annual Meeting
Feb 21, 2019
Statement from FDA Commissioner Scott Gottlieb, M.D., on additional steps by the agency to support the development of safe and effective novel nicotine replacement therapies to help smokers quit cigarettes
Feb 20, 2019
Achieve Life Sciences Announces Completion of Enrollment in 254-Subject Phase 2b Trial of Cytisinicline for Smoking Cessation
Dec 18, 2018
Achieve Announces Update on Cytisinicline Clinical Development Program
Nov 15, 2018
Results from 2018 National Youth Tobacco Survey show dramatic increase in e-cigarette use among youth over past year
Nov 01, 2018
Trick or Treat! Don't Be Fooled by Industry Support of Tobacco 21
Oct 31, 2018
Achieve Life Sciences to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018
Oct 30, 2018
Achieve Life Sciences Announces Initiation of Phase 2b ORCA-1 Trial Evaluating Cytisinicline (cytisine) for Smoking Cessation
Oct 22, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on agency's ongoing commitment to improving efficiency, transparency of tobacco product application review process as part of FDA's comprehensive framework to reduce tobacco-related disease and death
Sep 27, 2018
Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects
Sep 26, 2018
Achieve to Present at the Ladenburg Thalmann 2018 Healthcare Conference on October 2, 2018